tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ADAP Stock Latest News

Adaptimmune Faces Nasdaq Delisting Notice Amid Compliance Issues
Company AnnouncementsAdaptimmune Faces Nasdaq Delisting Notice Amid Compliance Issues
6h ago
8K
ADAP
Adaptimmune Reports Growth and Strategic Moves in Q2
PremiumCompany Announcements
Adaptimmune Reports Growth and Strategic Moves in Q2
23h ago
ADAP
Adaptimmune Announces Termination of Chief Medical Officer
PremiumCompany Announcements
Adaptimmune Announces Termination of Chief Medical Officer
7d ago
8K
ADAP
Adaptimmune Sells Cell Therapy Assets for $55 Million
PremiumCompany Announcements
Adaptimmune Sells Cell Therapy Assets for $55 Million
14d ago
8K
ADAP
Hold Rating Maintained for Adaptimmune Therapeutics Amid Strategic Asset Sale and Leadership Changes
PremiumRatings
Hold Rating Maintained for Adaptimmune Therapeutics Amid Strategic Asset Sale and Leadership Changes
16d ago
ADAP
Adaptimmune downgraded to Neutral from Buy at Guggenheim
PremiumThe FlyAdaptimmune downgraded to Neutral from Buy at Guggenheim
16d ago
ADAP
Adaptimmune downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Adaptimmune downgraded to Neutral from Buy at H.C. Wainwright
17d ago
ADAP
Adaptimmune Sells Cell Therapy Assets to US WorldMeds
Premium
Company Announcements
Adaptimmune Sells Cell Therapy Assets to US WorldMeds
18d ago
8K
ADAP
Adaptimmune Settles Litigation with M.D. Anderson Cancer Center
PremiumCompany Announcements
Adaptimmune Settles Litigation with M.D. Anderson Cancer Center
28d ago
8K
ADAP
General Mills upgraded, Trade Desk downgraded: Wall Street’s top analyst calls
PremiumThe Fly
General Mills upgraded, Trade Desk downgraded: Wall Street’s top analyst calls
2M ago
U
FDS
Mizuho downgrades Adaptimmune to Neutral on solvency concerns
PremiumThe Fly
Mizuho downgrades Adaptimmune to Neutral on solvency concerns
2M ago
ADAP
Adaptimmune downgraded to Neutral from Outperform at Mizuho
PremiumThe Fly
Adaptimmune downgraded to Neutral from Outperform at Mizuho
2M ago
ADAP
Adaptimmune’s Annual Meeting Focuses on Shareholder Engagement
PremiumCompany AnnouncementsAdaptimmune’s Annual Meeting Focuses on Shareholder Engagement
3M ago
8K
ADAP
Hold Rating for Adaptimmune Therapeutics Amid Strategic Progress and Financial Uncertainties
Premium
Ratings
Hold Rating for Adaptimmune Therapeutics Amid Strategic Progress and Financial Uncertainties
3M ago
ADAP
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
INM
XLO
Adaptimmune’s Earnings Call: Success Amid Financial Concerns
PremiumCompany Announcements
Adaptimmune’s Earnings Call: Success Amid Financial Concerns
3M ago
ADAP
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
BMY
ABBV
Cautious Hold on Adaptimmune Therapeutics Amid Strategic Developments and Liquidity Concerns
PremiumRatings
Cautious Hold on Adaptimmune Therapeutics Amid Strategic Developments and Liquidity Concerns
3M ago
ADAP
Promising Growth Prospects and Strategic Advancements Drive Buy Rating for Adaptimmune Therapeutics
PremiumRatings
Promising Growth Prospects and Strategic Advancements Drive Buy Rating for Adaptimmune Therapeutics
3M ago
ADAP
Adaptimmune price target lowered to $1 from $1.50 at Wells Fargo
PremiumThe FlyAdaptimmune price target lowered to $1 from $1.50 at Wells Fargo
3M ago
ADAP
Adaptimmune price target lowered to 46c from $1 at Barclays
Premium
The Fly
Adaptimmune price target lowered to 46c from $1 at Barclays
3M ago
ADAP
Adaptimmune Therapeutics Reports Q1 2025 Earnings
Premium
Company Announcements
Adaptimmune Therapeutics Reports Q1 2025 Earnings
3M ago
ADAP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >